ASS stabilization [Bioanalytics]

posted by Helmut Homepage – Vienna, Austria, 2019-02-02 16:56 (724 d 16:00 ago) – Posting: # 19848
Views: 1,264

Hi Norah,

» I'm preparing a BE protocol regarding, enteric delaying release aspirin […] Could you please tell me what are you recommendations to avoid the degradation of active ingredient in metabolite.

In my CRO we had two methods (anticoagulant K3EDTA or Li-heparin). Example for 10 mL vacutainers.
  1. Stabilizer H3PO4
    Prepare 5% orthophosporic acid (59 mL 85% o-H3PO4 p.a. diluted to 1000 mL).
    Caution: Even diluted phosphoric acid is strongly acidic; wear gloves and eye protection.
  2. Stabilizer potassium fluoride
    Prepare cold saturated KF solution (100 g KF p.a. in 100 ml water).
    Caution: KF is poisonous. Observe the usual rules.
Penetrate the stopper of 10 mL vacutainers (e.g., by a 200–500 µL HPLC syringe with a thin needle) and inject 100 µl of the respective stabilizer. Use these for all samples.

Handling & storage

Put blood samples immediately after draw in an ice-bath. Allow 10 minutes for equilibration and centrifuge at ~2000×g at +4 ℃ for 20 minutes.

  1. Mix plasma with 5% H3PO4 1:1 (exactly!). Store at ≤20 ℃.
  2. Store at ≤70 ℃.
If you have no problems with sensitivity I would suggest #1. However, the final dilution step is labour-intensive. #2 gives a ~2times lower LOQ but the deep-freezer will suck up a lot of electricity…

Dif-tor heh smusma 🖖
Helmut Schütz

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

 Admin contact
21,316 posts in 4,446 threads, 1,489 registered users;
online 6 (0 registered, 6 guests [including 3 identified bots]).
Forum time: Wednesday 08:57 CET (Europe/Vienna)

Nothing fails like success because you do not learn anything from it.
The only thing we ever learn from is failure.
Success only confirms our superstitions.    Kenneth E. Boulding

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz